U.S. markets open in 8 hours 49 minutes

Concord Medical Services Holdings Limited (CCM)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
2.9603+0.0100 (+0.34%)
At close: 3:18PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close2.9503
Open2.8800
Bid0.0000 x 1000
Ask0.0000 x 3200
Day's Range2.8800 - 3.0000
52 Week Range1.4500 - 5.8900
Volume12,651
Avg. Volume18,596
Market Cap128.518M
Beta (5Y Monthly)0.22
PE Ratio (TTM)N/A
EPS (TTM)-2.0600
Earnings DateAug 23, 2021 - Aug 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 23, 2015
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou
    PR Newswire

    Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that its Guangzhou Concord Cancer Center ("GCCC"), which is certified as a tertiary specialty hospital by the National Health Commission, is now in operation. This has mark

  • Concord Medical Receives Notification from NYSE Regarding Delayed Filing of 2020 Annual Report
    PR Newswire

    Concord Medical Receives Notification from NYSE Regarding Delayed Filing of 2020 Annual Report

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that as of May 25, 2021, it is late in filing its annual report on Form 20-F for the fiscal year ended December 31, 2020 (the "2020 Annual Report") with the Securities and Exchange Commission (the "SEC"). The Company previously filed a Form 12b-25 with the SEC on April 30, 2021 for late filing of the 2020 Annual Report, pursuant to which the 2020 Annual Report was due to be filed by May 17, 2021. The Company expects to file the 2020 Annual Report once the audit of the Company's financial statements for the fiscal year ended December 31, 2020 is complete.

  • Concord Medical Announces Changes in Board of Directors
    PR Newswire

    Concord Medical Announces Changes in Board of Directors

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced changes in its board of directors (the "Board").